Search filters

List of works by Marco Ruella

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cells

scientific article published on 01 February 2020

A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera.

scientific article published on 16 August 2014

A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept.

scientific article

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.

scientific article published on 17 December 2015

Adoptive immunotherapy for cancer.

scientific article published on January 2014

Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cells

scientific article published on 22 April 2021

Beat pediatric ALL MRD: CD28 CAR T and transplant

scientific article published on 01 December 2019

Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.

scientific article published on 22 November 2017

CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone before

scientific article published on 21 November 2020

CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia

scientific article

Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies

scientific article

Chimeric antigen receptor T-cell therapy to target hematologic malignancies

scientific article published on 4 November 2014

Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere status

scientific article published on 19 October 2009

Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy

scientific article

Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies

scientific article

EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models ⬇️

scientific article published in February 2025

Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer

scientific article published on 16 October 2017

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

scientific article published in 2022

Haploidentical cellular therapy in elderly patients with acute myeloid leukemia: description of its use in high risk patients.

scientific article published on 28 June 2013

How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia.

scientific article published on 2 February 2015

Human chimeric antigen receptor macrophages for cancer immunotherapy

scientific article published on 23 March 2020

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

scientific article published on 26 January 2016

Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction

scientific article published on 30 January 2020

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

scientific article published on 01 October 2018

Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms.

scientific article published on 28 September 2016

Long-Term Results of Autologous Hematopoietic Stem-Cell Transplantation After High-Dose 90Y-Ibritumomab Tiuxetan for Patients With Poor-Risk Non-Hodgkin Lymphoma Not Eligible for High-Dose BEAM.

scientific article published on 15 July 2013

Lymphocyte transformation and autoimmune disorders.

scientific article published on 04 December 2012

Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluation

scientific article published on 11 October 2013

Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia

scientific article published on 12 May 2011

Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf.

scientific article published on 16 November 2017

Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia

scientific article published on 28 February 2017

Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells.

scientific article published on 2 June 2017

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).

scientific article published on 11 July 2018

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells

scientific article published on 04 March 2014

Pregnancy complications predict thrombotic events in young women with essential thrombocythemia.

scientific article published on 19 February 2014

Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survival

scientific article

Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma

scientific article

Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: A biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy ⬇️

scientific article published on March 28, 2013

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma.

scientific article published on 27 January 2016

The aging effect of chemotherapy on cultured human mesenchymal stem cells.

scientific article

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells.

scientific article published on 4 November 2015

Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report

scientific article

Walking a tightrope: clinical use of ibrutinib in mantle cell lymphoma in the elderly.

scientific article published on December 2016

Paulina is supported by:

About Paulina

Help